QA: GlobeStar Therapeutics Corp in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001502152_2021_GlobeStar_Therapeutics_Corp.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001502152')"}

Graph

Absolute values for 0001502152, GlobeStar Therapeutics Corp

  xvar xval
0 AssetsCurrent 88,637
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,275
3 remainder_Assets 0
4 LiabilitiesCurrent 749,134
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 37,682
8 SellingGeneralAndAdministrativeExpense 266,066
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 238,060
11 remainder_Revenues 77.0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 89,912
1 Liabilities 749,134
2 Expenses 541,808
3 Revenues 77.0
4 StockholdersEquity -659,222
5 NetIncome -541,731
6 ComprehensiveNetIncome -541,731
7 BaseVar 690,466
8 EconomicCapitalRatio -3.99

Edgar->Model Mapping

Feature Distribution

Change over Time